
    
      The objective of the CAPTIVATE Clinical Study is to gather data to establish the safety and
      effectiveness of the PaceSafe Right Ventricular Autothreshold (RVAT) and Left Ventricular
      Autothreshold (LVAT) features to support the regulatory approval of the AUTOGEN CRT-D family
      of devices.
    
  